| 产品详情 |
| Edit |   |
|---|
| Product Name | 6-Desacetyl-6-bromo-N-Boc Palbociclib |
|---|
| Description | 6-Desacetyl-6-bromo-N-Boc Palbociclib is an impurity of Palbociclib (P139900),(also known as compound number PD-0332991) is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Also, it is derived from 6-Bromo-2-chloro-8-cyclopentyl-5-methylpyrido-[2,3-d]pyrimidin-7(8H)-one (B682195), which is used to prepare pyridino[2,3-d]pyrimidin-7(8H)-one derivatives as CDK4 and/or CDK6 inhibitors useful in the treatment of diseases. Molecular Formula: C27H34BrN7O3 Molecular Weight: 584.51 |
|---|
| Size | 25mg, 50mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | n/a |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | 438496 |
|---|
| Price | |
|---|
| Order / More Info | 6-Desacetyl-6-bromo-N-Boc Palbociclib from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|